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Introduction
Biomarkers of cardiomyocyte injury, cardiac troponin T and I (cTnT and cTnI), are integral to the diagnosis of acute myocardial infarction (AMI) 1, 2 . Although these markers have been used clinically for decades, the detailed triggers and mechanisms of their release are still incompletely understood. A better understanding of their triggers could potentially help make better use of these markers of cardiomyocyte injury in the evaluation of acute chest pain. Therefore we explored the association of hemodynamic cardiac stress, as quantified by B-type natriuretic peptide (BNP) and N-terminal proBNP levels (NT-proBNP) [3] [4] [5] [6] , with levels of high-sensitivity cTnT, cTnI, myoglobin, and CK-MB among chest pain patients presenting to the Emergency Department (ED).
Methods
The Advantageous Predictors of Acute Coronary Syndromes Evaluation (APACE) study is an ongoing prospective, international, multicenter study designed . NT-proBNP was measured using the Elecsys 2010 system (Roche Diagnostics). The CK-MB mass was measured using the Elecsys CK-MB immunoassay (Roche Diagnostics, Rotkreuz, Switzerland) with a measuring range of 0.1 -500 ng/mL and a coefficient of variation of 2.1-3.5% at 5.6 ng/mL. Myoglobin mass was measured using the Elecsys Myoglobin immunoassay (Roche Diagnostics, Rotkreuz, Switzerland) with a measuring range of 21-3'000 ng/mL and a coefficient of variation (intermediate precision) of 1.8-2.3% at 36 ng/mL.
Results and Discussion
A total of 831 patients had BNP, cTnT, myoglobin, and CK-MB levels measured at presentation; and cTnI-ultra was available in 807 (97%) patients.
Median time for onset of chest pain to ED presentation was 6 hours. Table 1 shows the baseline characteristics of patients.
The major novel finding of our study is that the positive pair-wise correlation with BNP was strongest for hs-cTnT and cTnI-ultra (r=0.58 and 0.50, respectively), When stratified according to the BNP tertiles ( Table 2 A), no biomarker significant correlated with BNP (p>0.05) among patients within the first BNP tertile group. When stratified according to the BNP tertiles and time since onset of chest pain (Appendix B), similar results were seen in first and third tertile, but interestingly in the 2nd tertile, the hs-cTnT and cTnI-ultra significantly correlated with BNP only in those who presented early (≤6 hours) but not in late presenters (>6 hours).
We also confirmed the finding of increased hemodynamic stress among AMI patients as highlighted by increased BNP 10 . In AMI, impaired blood flow results in ischemia, infarction and increased hemodynamic stress. Figure 2 shows the box plot levels of four investigational markers according to the final diagnosis. Another major finding of our study is that when stratified according the five groups of final adjudicated diagnosis (Table 2 B) , CK-MB was the only marker that did not significantly correlate with BNP among cardiac but non-coronary and non-cardiac
cause of chest pain patients. The strong correlation with BNP for hs-cTnT and cTnIultra persisted even in patients adjudicated to have non-cardiac causes of chest pain.
The 3 biomarkers for cardiomyocyte injury (cTnT, cTnI, myoglobin, and CK-MB) significantly correlated with each other in all patients and within each subgroup by BNP tertiles, final diagnoses and onset of chest pain.
Overall, these findings were confirmed in the subgroup of patients (n=502) in which also levels of NT-proBNP were available and used for the quantification of hemodynamic cardiac stress. (Supplementary Table S1 and S2 and Figure S2 ).
The sequence of events resulting in cardiomyocyte injury is unclear, however hemodynamic cardiac stress itself might likely be the cause of cardiomyocyte injury, indicating it is more common than previously thought and not restricted to acute cardiac conditions. The phenomenon of hemodynamic cardiac stress induced cardiomyocyte injury has first been described in patients with acute heart failure 11, 12 .
We can only hypothesize why increased hemodynamic cardiac stress leads to a predominate release of cTnT and I, as assessed by sensitive assays, and myoglobin rather than CK-MB. Potential reasons include the different mechanism of release, release kinetics including the half lives of the markers (13), different levels of injury necessary to result in the loss of these structural cardiomyocyte proteins and different reflection of reversible and irreversible injury (1, 14, 15). Another possible explanation is the relative difference in the tissue concentrations between the different biomarkers. Our data highlight that this seems to be a graded and possible continuous phenomenon.
Several limitations of the study merit consideration. First, the vast majority of patients were Caucasians and terminal renal failure patients were excluded.
Therefore, the impact of race and terminal renal failure on biomarker association could not be determined. Second, as an observational study, we are unable to test
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7 the clinical benefit nor establish a causal link between BNP or NT-proBNP with cardiomyocyte injury biomarkers (ie whether hemodynamic stress occurred before or after index event). Third, the onset of chest pain time is the only kinetic measure that was explored in this study. Fourth, heart failure is known to lead to both cTn and BNP elevations, and its potential as a confounding factor was not studied. History of heart failure was not recorded in the case report form. However, the results of the study were unchanged even when patients on diuretics, n=214 (26%), were removed from the analyses. Fifth, there were several other factors (mainly those found significantly different among the three tertile groups as in table 1, such as age, CAD etc) that are potential confounders and were not assessed.
Conclusion
Hemodynamic cardiac stress, as quantified by BNP (or NT-proBNP) levels, is more closely reflected by concentrations of hs-cTnT, cTnI-ultra and Myoglobin than CK-MB. Our study findings support the use of cTnI and T for the detection of myocardial injury during increased hemodynamic stress. Furthermore, increased hemodynamic stress and myocardial injury is commonly seen among acute chest pain patients, even among those diagnosed with a non-cardiac cause of chest pain.
Further research is needed to explore the kinetic differences in BNP and cTn. Table S1 shows the baseline characteristics of all patients and also according to the N-terminal pro B-type Natriuretic peptide (NT-proBNP) tertiles. The medications are those, which the patients were taking at the time of admission.
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Baseline characteristics (n = 502) Table B Correlation with BNP and:
Final Adjudicated diagnosis Figure 1 shows the scatter plots between log transformed B-type Natriuretic peptide (BNP) and A) Creatine Kinase-Myocardial Band (CK-MB), B) Myoglobin, C) highsensitivity cardiac troponin-T (hs-cTnT) and D) Siemens Ultra cardiac troponin I (cTnI-ultra). Figure 2 shows the box plot levels of B-type Natriuretic peptide (BNP) and Creatine Kinase-Myocardial Band (CK-MB), Myoglobin, high-sensitivity cardiac troponin-T (hscTnT) and Siemens Ultra cardiac troponin I (cTnI-ultra) according to the final diagnosis. The boxes represent interquartile ranges, the horizontal line in each box represents the median, and the whiskers show the minimum and maximum values (excluding outliers that were more than 1.5 times the values represented at each end of the box).
Supplementary Figure   Figure S1 shows the scatter plots between log transformed N-terminal pro B-type Natriuretic peptide (NT-proBNP) and A) Creatine Kinase-Myocardial Band (CK-MB), B) Myoglobin, C) high-sensitive cardiac troponin-T (hs-cTnT) and D) Siemens Ultra cardiac troponin I (cTnI-ultra). 
